Vistas | |
---|---|
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics | 186 |
noviembre 2024 | diciembre 2024 | enero 2025 | febrero 2025 | marzo 2025 | abril 2025 | mayo 2025 | |
---|---|---|---|---|---|---|---|
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics | 3 | 3 | 6 | 9 | 10 | 20 | 1 |
Vistas |
---|
Vistas |
---|